Uterin Myomların Yönetimi

Baird DD, Dunson DB, Hill MC, Cousins D, Schectman JM. High cumulative incidence of uterine leiomyoma in black and white women: ultrasound evidence. Am J Obstet Gynecol 2003;188:100–7.

Ezzati M, Norian J, Segars J. Management of uterine fibroids in the patient pursuing assisted reproductive technologies. Women's Health (Lond Engl). 2009; 5:413–21.

Bulun SE. Uterine fibroids. N Engl J Med. 2013;369(14):1344–1355.

Makinen N, Mehine M, Tolvanen J, et al. MED12, the mediator complex subunit 12 gene, is mutated at high frequency in uterine leiomyomas. Science. 2011;334(6053):252–255

Munro MG, Critchley HOD, Broder MS, Fraser IS. FIGO classification system (PALM–COEIN) for causes of abnormal uterine bleeding in nongravid women of reproductive age. Int J Gynaecol Obstet. 2011;113(1):3–13.

Stewart EA. Clinical practice. Uterine fibroids. . N Engl J Med 2015;372:1646–55.

Leppert PC, Jayes FL, Segars JH. The extracellular matrix contributes to mechanotransduction in uterine fibroids. Obstet Gynecol Int. 2014;2014:783289.

Pritts EA, Parker WH, Olive DL. Fibroids and infertility: an updated systematic review of the evidence. Fertil Steril. 2009;91(4):1215–1223.

Yan L, Ding L, Li Q, et al. Impact of intramural fibroids not distorting the endometrial cavity on the outcome of IVF-ET. Reprod Biol Endocrinol. 2018;16:49.

Coronado GD, Marshall LM, Schwartz SM. Complications in pregnancy, labor, and delivery with uterine leiomyomas: a population-based study. Obstet Gynecol. 2000;95(5):764–769.

Dueholm M, Lundorf E, Hansen ES, Ledertoug S, Olesen F. Accuracy of magnetic resonance imaging and transvaginal ultrasonography in the diagnosis, mapping, and measurement of uterine myomas. American journal of obstetrics and gynecology. 2002 Mar 1;186(3):409-15.

Cook H, Ezzati M, Segars J, et al. The impact of uterine leiomyomas on reproductive outcomes. Minerva Ginecol. 2010;62:225–36.

Donnez J, Jadoul P. What are the implications of myomas on fertility? A need for a debate? Hum Reprod. 2002;17:1424–30. doi: 10.1093/humrep/17.6.1424.

Erden M, Uyanik E, Polat M, Ozbek IY, Yarali H, Mumusoglu S. The effect of≤ 6 cm sized noncavity-distorting intramural fibroids on in vitro fertilization outcomes: a systematic review and meta-analysis. Fertility and Sterility. 2023 Jun 1;119(6):996-1007.

Surrey ES. Myomas and assisted reproductive technologies. Semin Reprod Med. 2010;28(3):234–240.

Rackow BW, Taylor HS. Submucosal uterine leiomyomas have a global effect on molecular determinants of endometrial receptivity. Fertil Steril. 2010;93(6):2027–2034.

Yoshino O, Hayashi T, Osuga Y, et al. Decreased uterine receptivity caused by uterine fibroids is associated with reduced HOXA10 expression. J Clin Endocrinol Metab. 2006;91(3):1295–1299.

Yoshino O, Hayashi T, Osuga Y, Orisaka M, Asada H, Okuda S, Hori M, Furuya M, Onuki H, Sadoshima Y, Hiroi H. Decreased pregnancy rate is linked to abnormal uterine peristalsis caused by intramural fibroids. Human reproduction. 2010 Oct 1;25(10):2475-9.

Zannotti A, Greco S, Pellegrino P, Giantomassi F, Delli Carpini G, Goteri G, Ciavattini A, Ciarmela P. Macrophages and immune responses in uterine fibroids. Cells. 2021 Apr 22;10(5):982.

Ciarmela P, Carpini GD, Greco S, Zannotti A, Montik N, Giannella L, Giuliani L, Grelloni C, Panfoli F, Paolucci M, Pierucci G. Uterine fibroid vascularization: from morphological evidence to clinical implications. Reproductive BioMedicine Online. 2022 Feb 1;44(2):281-94.

Yao X, Stewart EA, Laughlin‐Tommaso SK, Heien HC, Borah BJ. Medical therapies for heavy menstrual bleeding in women with uterine fibroids: a retrospective analysis of a large commercially insured population in the USA. BJOG: An International Journal of Obstetrics & Gynaecology. 2017 Jan;124(2):322-30.

Hartmann KE, Fonnesbeck C, Surawicz T, Krishnaswami S, Andrews JC, Wilson JE, Velez-Edwards D, Kugley S, Sathe NA. Management of uterine fibroids. AHRQ comparative effectiveness review. Rockville, MD. 2017. 2021

Mercorio F, De Simone R, Di Spiezio Sardo A, et al. The effect of levonorgestrel-releasing intrauterine device in the treatment of myoma-related menorrhagia. Contraception. 2003;67(4):277–280.

Donnez J, Tomaszewski J, Vázquez F, Bouchard P, Lemieszczuk B, Baró F, Nouri K, Selvaggi L, Sodowski K, Bestel E, Terrill P. Ulipristal acetate versus leuprolide acetate for uterine fibroids. New England Journal of Medicine. 2012 Feb 2;366(5):421-32.

Parsanezhad ME, Azmoon M, Alborzi S, Rajaeefard A, Zarei A, Kazerooni T, Frank V, Schmidt EH. A randomized, controlled clinical trial comparing the effects of aromatase inhibitor (letrozole) and gonadotropin-releasing hormone agonist (triptorelin) on uterine leiomyoma volume and hormonal status. Fertility and sterility. 2010 Jan 1;93(1):192-8.

Di Spiezio Sardo A, et al. Hysteroscopic myomectomy: a comprehensive review of surgical techniques. Hum Reprod Update. 2008;14(2):101–119.

Bosteels J, et al. Hysteroscopy for treating subfertility associated with suspected major uterine cavity abnormalities. Cochrane Database Syst Rev. 2015;(2):CD009461.

Metwally M, Raybould G, Cheong YC, Horne AW. Surgical treatment of fibroids for subfertility. Cochrane Database of Systematic Reviews. 2020(1).

Dubuisson JB, Fauconnier A, Deffarges JV, Norgaard C, Kreiker G, Chapron C. Pregnancy outcome and deliveries following laparoscopic myomectomy. Human Reproduction. 2000 Apr 1;15(4):869-73.

Jin C, Hu Y, Chen XC, Zheng FY, Lin F, Zhou K, Chen FD, Gu HZ. Laparoscopic versus open myomectomy—a meta-analysis of randomized controlled trials. European Journal of Obstetrics & Gynecology and Reproductive Biology. 2009 Jul 1;145(1):14-21.

Mara M, Maskova J, Fucikova Z, Kuzel D, Belsan T, Sosna O. Midterm clinical and first reproductive results of a randomized controlled trial comparing uterine fibroid embolization and myomectomy. Cardiovascular and interventional radiology. 2008 Jan;31:73-85.

Gupta JK, Sinha A, Lumsden MA, Hickey M. Uterine artery embolization for symptomatic uterine fibroids. Cochrane Database of Systematic Reviews. 2014(12).

Rabinovici J, David M, Fukunishi H, Morita Y, Gostout BS, Stewart EA, MRgFUS Study Group. Pregnancy outcome after magnetic resonance–guided focused ultrasound surgery (MRgFUS) for conservative treatment of uterine fibroids. Fertility and sterility. 2010 Jan 1;93(1):199-209.

Dolmans MM, Isaacson K, Zhang W, Gordts S, Munro MG, Stewart EA, Bourdon M, Santulli P, Donnez J. Intramural myomas more than 3–4 centimeters should be surgically removed before in vitro fertilization. Fertility and sterility. 2021 Oct 1;116(4):945-58.

Stout MJ, Odibo AO, Graseck AS, Macones GA, Crane JP, Cahill AG. Leiomyomas at routine second-trimester ultrasound examination and adverse obstetric outcomes. Obstetrics & Gynecology. 2010 Nov 1;116(5):1056-63.

Baird DD, Dunson DB, Hill MC, Cousins D, Schectman JM. High cumulative incidence of uterine leiomyoma in black and white women: ultrasound evidence. Am J Obstet Gynecol 2003;188:100–7.

Ezzati M, Norian J, Segars J. Management of uterine fibroids in the patient pursuing assisted reproductive technologies. Women's Health (Lond Engl). 2009; 5:413–21.

Bulun SE. Uterine fibroids. N Engl J Med. 2013;369(14):1344–1355.

Makinen N, Mehine M, Tolvanen J, et al. MED12, the mediator complex subunit 12 gene, is mutated at high frequency in uterine leiomyomas. Science. 2011;334(6053):252–255

Munro MG, Critchley HOD, Broder MS, Fraser IS. FIGO classification system (PALM–COEIN) for causes of abnormal uterine bleeding in nongravid women of reproductive age. Int J Gynaecol Obstet. 2011;113(1):3–13.

Stewart EA. Clinical practice. Uterine fibroids. . N Engl J Med 2015;372:1646–55.

Leppert PC, Jayes FL, Segars JH. The extracellular matrix contributes to mechanotransduction in uterine fibroids. Obstet Gynecol Int. 2014;2014:783289.

Pritts EA, Parker WH, Olive DL. Fibroids and infertility: an updated systematic review of the evidence. Fertil Steril. 2009;91(4):1215–1223.

Yan L, Ding L, Li Q, et al. Impact of intramural fibroids not distorting the endometrial cavity on the outcome of IVF-ET. Reprod Biol Endocrinol. 2018;16:49.

Coronado GD, Marshall LM, Schwartz SM. Complications in pregnancy, labor, and delivery with uterine leiomyomas: a population-based study. Obstet Gynecol. 2000;95(5):764–769.

Dueholm M, Lundorf E, Hansen ES, Ledertoug S, Olesen F. Accuracy of magnetic resonance imaging and transvaginal ultrasonography in the diagnosis, mapping, and measurement of uterine myomas. American journal of obstetrics and gynecology. 2002 Mar 1;186(3):409-15.

Cook H, Ezzati M, Segars J, et al. The impact of uterine leiomyomas on reproductive outcomes. Minerva Ginecol. 2010;62:225–36.

Donnez J, Jadoul P. What are the implications of myomas on fertility? A need for a debate? Hum Reprod. 2002;17:1424–30. doi: 10.1093/humrep/17.6.1424.

Erden M, Uyanik E, Polat M, Ozbek IY, Yarali H, Mumusoglu S. The effect of≤ 6 cm sized noncavity-distorting intramural fibroids on in vitro fertilization outcomes: a systematic review and meta-analysis. Fertility and Sterility. 2023 Jun 1;119(6):996-1007.

Surrey ES. Myomas and assisted reproductive technologies. Semin Reprod Med. 2010;28(3):234–240.

Rackow BW, Taylor HS. Submucosal uterine leiomyomas have a global effect on molecular determinants of endometrial receptivity. Fertil Steril. 2010;93(6):2027–2034.

Yoshino O, Hayashi T, Osuga Y, et al. Decreased uterine receptivity caused by uterine fibroids is associated with reduced HOXA10 expression. J Clin Endocrinol Metab. 2006;91(3):1295–1299.

Yoshino O, Hayashi T, Osuga Y, Orisaka M, Asada H, Okuda S, Hori M, Furuya M, Onuki H, Sadoshima Y, Hiroi H. Decreased pregnancy rate is linked to abnormal uterine peristalsis caused by intramural fibroids. Human reproduction. 2010 Oct 1;25(10):2475-9.

Zannotti A, Greco S, Pellegrino P, Giantomassi F, Delli Carpini G, Goteri G, Ciavattini A, Ciarmela P. Macrophages and immune responses in uterine fibroids. Cells. 2021 Apr 22;10(5):982.

Ciarmela P, Carpini GD, Greco S, Zannotti A, Montik N, Giannella L, Giuliani L, Grelloni C, Panfoli F, Paolucci M, Pierucci G. Uterine fibroid vascularization: from morphological evidence to clinical implications. Reproductive BioMedicine Online. 2022 Feb 1;44(2):281-94.

Yao X, Stewart EA, Laughlin‐Tommaso SK, Heien HC, Borah BJ. Medical therapies for heavy menstrual bleeding in women with uterine fibroids: a retrospective analysis of a large commercially insured population in the USA. BJOG: An International Journal of Obstetrics & Gynaecology. 2017 Jan;124(2):322-30.

Hartmann KE, Fonnesbeck C, Surawicz T, Krishnaswami S, Andrews JC, Wilson JE, Velez-Edwards D, Kugley S, Sathe NA. Management of uterine fibroids. AHRQ comparative effectiveness review. Rockville, MD. 2017. 2021

Mercorio F, De Simone R, Di Spiezio Sardo A, et al. The effect of levonorgestrel-releasing intrauterine device in the treatment of myoma-related menorrhagia. Contraception. 2003;67(4):277–280.

Donnez J, Tomaszewski J, Vázquez F, Bouchard P, Lemieszczuk B, Baró F, Nouri K, Selvaggi L, Sodowski K, Bestel E, Terrill P. Ulipristal acetate versus leuprolide acetate for uterine fibroids. New England Journal of Medicine. 2012 Feb 2;366(5):421-32.

Parsanezhad ME, Azmoon M, Alborzi S, Rajaeefard A, Zarei A, Kazerooni T, Frank V, Schmidt EH. A randomized, controlled clinical trial comparing the effects of aromatase inhibitor (letrozole) and gonadotropin-releasing hormone agonist (triptorelin) on uterine leiomyoma volume and hormonal status. Fertility and sterility. 2010 Jan 1;93(1):192-8.

Di Spiezio Sardo A, et al. Hysteroscopic myomectomy: a comprehensive review of surgical techniques. Hum Reprod Update. 2008;14(2):101–119.

Bosteels J, et al. Hysteroscopy for treating subfertility associated with suspected major uterine cavity abnormalities. Cochrane Database Syst Rev. 2015;(2):CD009461.

Metwally M, Raybould G, Cheong YC, Horne AW. Surgical treatment of fibroids for subfertility. Cochrane Database of Systematic Reviews. 2020(1).

Dubuisson JB, Fauconnier A, Deffarges JV, Norgaard C, Kreiker G, Chapron C. Pregnancy outcome and deliveries following laparoscopic myomectomy. Human Reproduction. 2000 Apr 1;15(4):869-73.

Jin C, Hu Y, Chen XC, Zheng FY, Lin F, Zhou K, Chen FD, Gu HZ. Laparoscopic versus open myomectomy—a meta-analysis of randomized controlled trials. European Journal of Obstetrics & Gynecology and Reproductive Biology. 2009 Jul 1;145(1):14-21.

Mara M, Maskova J, Fucikova Z, Kuzel D, Belsan T, Sosna O. Midterm clinical and first reproductive results of a randomized controlled trial comparing uterine fibroid embolization and myomectomy. Cardiovascular and interventional radiology. 2008 Jan;31:73-85.

Gupta JK, Sinha A, Lumsden MA, Hickey M. Uterine artery embolization for symptomatic uterine fibroids. Cochrane Database of Systematic Reviews. 2014(12).

Rabinovici J, David M, Fukunishi H, Morita Y, Gostout BS, Stewart EA, MRgFUS Study Group. Pregnancy outcome after magnetic resonance–guided focused ultrasound surgery (MRgFUS) for conservative treatment of uterine fibroids. Fertility and sterility. 2010 Jan 1;93(1):199-209.

Dolmans MM, Isaacson K, Zhang W, Gordts S, Munro MG, Stewart EA, Bourdon M, Santulli P, Donnez J. Intramural myomas more than 3–4 centimeters should be surgically removed before in vitro fertilization. Fertility and sterility. 2021 Oct 1;116(4):945-58.

Stout MJ, Odibo AO, Graseck AS, Macones GA, Crane JP, Cahill AG. Leiomyomas at routine second-trimester ultrasound examination and adverse obstetric outcomes. Obstetrics & Gynecology. 2010 Nov 1;116(5):1056-63.